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ABSTRACT
This thesis proposal shows the efficiency of different methods of Myostatin inhibition by using
CRISPR/CAS9. With the data cataloged by this thesis researchers will have a better
understanding on what methods are better to achieve their goals. The data were collected by
reading multiple scientific articles involving the usage of CRISPR/CAS9 to inhibit the Myostatin
protein. The data collected from all the different studies was analyzed in the same categories.
The experiment that used CRIPSR/CAS9 on in vitro specimens had a superior Myostatin
inhibition over all, therefore presenting higher muscle mass. The method using CRISPR/CAS9 to
inhibit the Myostatin in vivo and in vitro depends on what the researcher is trying to accomplish.
By reading this thesis researchers can understand that if they choose to use an in vitro treatment
the results would be way more severe than using an in vivo application treatment.
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SPECIFIC AIMS
In 2012, Dr. Jennifer Doudna proposed for the first time that CRISPR/cas9 could be used to
modify DNA [8]. Since then, the possibilities that this technology brought to the scientific
community seem to be endless. One type of research that has brought much attention is the
complete deletion of the Myostatin gene (MSTN) using CRISPR/cas9. Myostatin (MSTN) is
part of the transforming growth factor beta (TGF-) superfamily, acting as a negative regulator
of muscle mass, related to muscle growth [8]. Therefore, the absence of this gene allows the
muscle fibers to grow bigger and stronger. This MSTN treatment has been tried with a variety of
animals such as mice [9], rabbits [8], sheep [3], pigs [14], etc. The primary focus of these
experiments is to improve the size and weight of livestock animals. Researches seek to be able to
increase the meat harvest from one single animal to attend the increasing demand of food in the
near future. Most of the researchers seek generating a MSTN knockout animal using in vitro
techniques. However, not many researches are currently being conducted in vivo subjects. The
objective of this paper is to compare experiments that use CRISPR/cas9 to delete the MSTN
gene using in vivo and in vitro techniques and determine which one is the most efficient.
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BACKGROUND AND SIGNIFICANCE
The world population increases annually by 80 million [14]. Even though this number seems to
be decreasing as time passes, the United Nations has issued a graphic that shows the three
possible scenarios for world population growth. (Figure 1) [14].

Figure 1: World Population Growth 1950-2100 Source: UN, 2015. 2

The currently world population by the time of this article is 7.7 billion [4]. This number is
expected to increase by 2.03 billion in 2050, and 3.5 billion in 2100[14]. The U.N Department of
Economics and Social Affairs estimates that high-income countries such as the United States will
reach its peak population by 2040. While low and median-income countries in Africa and Asia
will show a decrease on its overall growth, but will still be growing according to the median
shown on figure 1[14]. China and other extremely populated countries will reach their peak in
between 2050 and 2060. With the increasing number of people, the demand for food will also
increase. In 2009 the Food and Agricultural Organization of the United States (FAO) stated that
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the food production worldwide would have to increase by 70% to meet the demand of the large
population by 2050[14]. However, the research done by the FAO has been outdated by the
previously mentioned UN research (2012). That shows a smaller growth needed. However, the
UN declare that the world food production has to increase by 50% until 2050 to meet the
demand. The demand for cereals such as wheat, oats and corn, is projected to reach 3 billion tons
by 2050. Meat production must grow from 200 million tons to 470 million tons in 2050 [1].

Agricultural production tripled between 1960 and 2015 [2], due to the technologies developed
during the Green Revolution, such as the use of chemical fertilizers and agro-chemicals among
other techniques [6]. Thirty years from now, in 2050, more than two-thirds of all people are is
expected to be living in urban areas [5]. It has been shown that agriculture has been and will
continued to be affected by the changes brought by urbanization [5]. Nowadays, a new array of
technologies is being used to increase the efficiency of crops and productions of food. Among
others, CRISPR/cas9 edited foods have been used in many areas of the food industry from the
development of longer shelf life tomatoes [17], to livestock animals with larger muscle tissue
[14].
The types of animals consumed world wide differ regarding on the nation religion, culture,
climate and population size. In the US for example, an average person eats 80kg to 60kg of
poultry, 60kg to 40kg of pork and 40kg to 20kg of beef per year [11]. Poultry is the most
consumed meat in the US due to its affordable price and its reputation of being a cleaner and
healthier meat [14]. In China, an average person eats 30kg of Pork, 10kg of poultry, 5kg of beef
[10]. Even though the gross amount of pork consumed by an average Chinese is smaller than the
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average American, pork meat is 66% of the total meat consumed by a Chinese per year, while
pork meat is only 33% of the meat consumed by an Americans. These populational preferences
encourage researchers to undergo experiments in different types of animals utilizing
CRISPR/cas9 aiming a similar goal, which is to increase the size of the animal. All experiments
with the same goal of disabling the MSTN gene therefore increasing the muscle tissue of the
animals. On this paper, four specific experiments were analyzed. Three of them seek to better
understand the effects of the deletion of the MSTN gene by the introduction of the CRISPR/cas9
treatment on its zygote (in vitro) in three different mammals’ species: rabbits [8], sheep [3], and
pigs [14]. Only one experiment seeks to use CIRSPR/cas9 on adult animals (in vivo). However,
the purpose of the in vivo experiment is to create a treatment that will disrupt MSNT and prevent
muscle-wasting syndrome [9] by also utilizing the same technology of CRISPR/cas9.
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RESEARCH AND METHODS
Three criteria were chosen to compare the efficiency of each in vitro experiment. These criteria
include: the overall percentage amount of the successfully breed MSTN (-/-) animals, the overall
difference in the body weight of successfully edited animal MSTN (-/-) to wild type MSTN (+/+)
and the visual presence of a double muscular phenotype.
The overall percentage amount of the successfully MSTN (-/-) animals will be represented as
OPAS. OPAS is calculated in each experiment is calculated by the following formula:
𝑂𝑃𝐴𝑆𝑣𝑖𝑡𝑟𝑜 =

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑏𝑜𝑟𝑛 𝑎𝑛𝑖𝑚𝑎𝑙𝑠 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑛𝑔 𝑀𝑆𝑇𝑁 (−/−)
× 100
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑛𝑖𝑚𝑎𝑙𝑠 𝑏𝑜𝑟𝑛

To find this information, each of the three research papers were carefully analyzed for
information regarding the number of born animals and the number of animals mutated. Although
all the experiments used CRISPR/cas9 to inhibit the myostatin gene loci, it is important to
emphasize that each experiment was conducted in a different way, altering the stage where
CRISPR was introduced and possibly the efficiency of OPAS. In the first experiment, using
rabbits as research model, the cas9 mRNA and sgRNAs were micro injected in to 158 zygotes.
The fertilized zygotes already containing the CRISPR/cas9 complex were then injected in to the
oviducts of the female rabbits [8]. The second experiment, using sheep as research model, went a
little further with the use of in vitro fertilization. Cast 9 mRNA was injected in to 216 fertilized
zygotes that were cultivated into 53 blastocysts [3]. These blastocysts were later transferred to
the female recipients by a surgery procedure assisted by laparoscopy was done to place the
embryos in the cranial side of the ipsilateral uterine horn to the corpus luteum [3]. The
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experiment using Chinese Erhualian pigs as a model was the most complex in terms of creating
the in vitro zygote. Porcine Fetal Fibroblasts were isolated from 33-day-old fetuses. Then it was
cultured in high glucose Dubelcco’s modified Eagle medium supplemented with 10% FBS, a
mixture of penicillin and streptomycin and non-essential amino acids that later undergo
electroporation to become a single cell colony [14]. Cas9 mRNA is injected in these cultures
before undergoing electroporation. Target regions on single cells colony are amplified by PCR
[14]. To create homozygous mutated MSTN (-/-) KO pigs, the single cells colonies are pooled as
donor cells for somatic cell nuclear transfer (SCNT). The overall percentage amount of the
successfully breed MSTN (-/-) for each experiment is: Erhualian pigs have a OPAS of 86.95%,
sheep have a OPAS of 36.36% and rabbits have a OPAS of 80% (Figure 2).

Figure 2: Percentage of OPAS among the animals in each study.

For the sake of this thesis proposal, the success of one experiment on the OPAS category was
simply measured by the amount percentage. In the Erhualian pigs experiment, 10 females
received an average of 200 fertilized embryos, but only five became pregnant [13]. It is true that
from the 23 pigs born, 20 were successfully mutated (hence OPAS 86.95%), but researches do
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not have the ability to determine if unsuccessful fertilization of the other 5 females is related with
the CRISPR/cas9 induced mutation, or to other possible problems. Such as the rabbit experiment,
from the 20 pups born, all 20 where successfully mutate. Still, four of them where MSTN (+/-)
that is, presented only one copy of the gene deleted and the other present. As for the sheep
experiment, 29 females were recipients of the blastocysts. From the 29, only 19 became pregnant
giving birth to 22 lambs. From the 22 lambs, only 10 had a mutation and from the 10 mutated
only 8 were homozygous MSTN (-/-).

The second criteria determined to analyze the efficiency of the CRISPR/cas9 treatment is the
overall difference in the body weight of successfully edited animal MSTN (-/-) to wild type
MSTN (+/+). Unfortunately, for this research, the experiment involving Erhualian pigs failed to
provide the amount in kg of both homozygous negative mutated pigs and the wild type, making
it impossible to calculate the percentage difference from the two types. However, this
information was successfully provided in both other experiments. The rabbits were weighted
throughout a period of 2 months. Although the report includes pictures of the three types of
rabbits, it only provided weight information of MSTN (+/-) and Wild Type (WT). Both types of
rabbits (WT and MSTN (+/-)) had similar weights until to the third week of life. After the fourth
week, the mutated rabbits started to show significant increase of the body weight. Within 8
weeks results show that the MSTN (+/-) were 15% to 30% heavier than the Wild Type in total
body mass [8]. The muscles of the tongue (T), heart (H), gluteus maximus (G) and vastus
lateralis (V) also were extracted for comparison. The only one from the four mentioned above
that has a significant increase is the gluteus Maximus, with an average increase of 35% heavier
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than the WT [8]. Heterozygous MSTN (-/-) rabbit showed a tongue 30% bigger than the WT.
The article did not state any type of information regarding the difference between the size of the
jaw on both phenotypes. Myostatin is a protein that controls inhibition only in muscles. Since the
jaw is made of bones, cartilage and muscle tissue, it is not expected for the entire jaw to grow.
The researcher did mention that MSTN (-/-) rabbits appears to be normal, healthy and had no
reproduction problems [8]. Therefore, we can presume that the increase of the tongue size does
not interfere much on the life of the animal.

The sheep were weighed throughout the first 60 days of life. All three types had the similar
weight at birth. After the first 15 days of life, the weight from the three types of sheep analyzed
started to differentiate [3]. Body weight of MSTN -/- sheep were in average 20% to 30% heavier
than the WT. While some heterozygous sheep MSTN (+/-) showed some increase of body
weight, some heterozygous did not showed the same result and end up having similar weight
than wild type animals [3]. It is important to mention that extremes from both types of sheep
have their weight compared to come to the previous analysis, this being, the heavier WT sheep
has a similar weight of the lightest heterozygous MSTN sheep.

Taking an average estimate with all the information provided by the three articles, it is possible
to assume that an animal that displays the successful inhibition of the MSTN gene (+/- or -/-)
will have at least 15% increase on its body mass within the first year.
Third criteria analyzed the visual presence of a double muscular phenotype. This is important to
differentiate the volume difference between wild type and MSTN (-/-). The visualization of the
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double muscular phenotype helps to predict that the animal meat actually grew bigger, instead of
just become heavier. Fortunately, all three experiments provided clear pictures from animals
where the double muscular phenotype is easily visible. The experiment that used rabbits as
research model provided pictures from the wild type animals and the two types of mutated
animals. In the picture stated above, it is possible to spot the difference between the three types
of phenotypes. It also makes possible to understand why the double negative homozygous
MSTN gene is the preferable to create animals which the purpose is only to have their meat
harvested.

In conclusion, the rabbit experiment had an 80% efficiency to generate MSTN (-/-) and 15% to
30% heavier MSTN (-/-) than WT. The sheep experiment had 36.36% efficiency to generate
MSTN (-/-) and 20% to 30% heavier MSTN (-/-) than WT. Also, the Erhualian experiment pigs
had 86.95% efficiency to generate MSTN (-/-) but an unknown increase of the weight of MSTN
(-/-) than WT.

The focuses of this thesis is to determine which CRISPR/cas9 treatment is the most efficient
between in vitro and in vivo. Therefore, the three criteria used to compare the past three in vitro
experiments are also used to qualify the in vivo experiment, even though they do not share the
same purpose. As mentioned in the beginning, the in vivo experiment did not share the same
method of research as the other three in vitro. However, the goal of the four experiments were
similar since all four wanted to increase muscle mass. The in vivo rat experiment looked for a
way to treat the genetic disease Duchenne Muscula dystrophin. Duchenne Muscula dystrophin is

10

a genetic disease that causes muscular dystrophy and lack of muscle control [9]. It affects the
DMD gene, which is responsible for creating the Dystrophin protein [9]. Dystrophin main
function is to connect the cytoskeleton of a muscle fiber to the ECM through the cell membrane.
The researchers used a technique called adeno-associated virus (AAV). CRISPR/cas9 complex
targeting the DMD gene was placed inside a virus capsule [9]. Then, the serum with the virus
already containing the CRISPR/cas9 complex was injected in to the mice muscle [9]. The exact
number of animals used in the mice experiment is not delivered in the paper. The author only
mentions that groups of six-week-old male mice are used where each group contains 6 mice [9].
Still, the amount of groups analyzed is also not shared. Yet, the author describes the overall
efficiency of the genome editing in muscle tissue as low (5%) [9]. For the purpose of this thesis
proposal, OPAS for the mice in vivo treatment will be 5%. Second criterion is the overall
difference in the body weight of successfully edited animal MSTN (-/-) to wild type MSTN
(+/+). Again, the author fails to share the exact weigh of the mice studied, but describe that the
average weigh of the gastrocnemius and soleus muscle increased by 9% [9]. The third criterion is
not met since the article did not provide any picture, making it impossible to determine if there is
a visible expression of the double muscular phenotype.
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CONCLUSION
After carefully analyzing all the results for each category, the results are the following:
The overall percentage amount of the successfully MSTN (-/-) animals (OPAS) for in vitro
treatments is higher than the in vivo treatment by 62.7% (figure 9).

Figure 3 Comparison of OPAS Between Species Presented in the study

The average of the overall difference in the body weight of successfully edited animal MSTN (-/) to wild type MSTN (+/+) for the in vitro experiments (estimating that the Erhualian pigs fall in
the same average as the sheep and the rabbit) is an increase of 23.3% on the body weight. While
the experiment in vivo had an average of 9%. Lastly, from the four experiment selected only
three provided pictures of the animals showing the double muscular phenotype. However, the
focus of these criteria was to prove that the increase of weight also means an increase of volume,
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and not increase of density. It is possible to estimate that the mice treated with CRISPR/cas9
from the in vivo experiment would likely show some increase on its muscle size. It is crucial to
understand that the even though the muscle growth from the vivo treatment were extremely
lower than the vitro. The vivo experiment was successful on its goal, which was to help to
restore dystrophy expression and improve muscle function on subjects with Duchenne Muscula
dystrophin [9].
As far as the aim for this thesis, the results show that if the goal is creating bigger animals,
scientist would have a higher rate of success if generating these animal from zygote, instead of
applying treatment to an existent livestock farm. In order to decide if those animals would be
cost benefice for business, other factors should be taken in consideration. If MSTN KO animals
are shown to be efficient, these animals could also help to stabilize the CO2 emissions generated
by livestock. Livestock is responsible for up to 14% of all greenhouse emissions [13]. An
average ruminant produces from 250 to 500 liter of methane per day [13]. When bigger animals
are created using CRISPR/cas9, the demand for a higher amount of livestock numbers decrease
since more meat can be harvest from one single animal. With that, the total number of livestock
would stop increasing, while the production of meat would still be able to grow.

One factor that has to be taken in consideration is the amount of food a MSTN KO animal will
need to keep increasing its size, compared to the amount of food consumed by a WT animal.
Muscle tissue consumes energy even at it is rest [7]. Humans spend in average 54.4 kJ per kg at
rest [7]. With that said, the higher the amount of muscles an animal has, higher the energy
necessity, bigger the amount of food require to maintain this animal. Since none of the
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experiments cited in this thesis allowed the animals to achieve adult phase, not much is known
about their diet and how much food they need to maintain muscle growth, further research is
needed in this area.
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